Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 1998, p. 1076-1082, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Characterization of the Antimonial Antileishmanial
Agent Meglumine Antimonate (Glucantime)
William L.
Roberts,1,*
Walter J.
McMurray,2,3 and
Petrie M.
Rainey3
Department of Pathology, University of
Mississippi Medical Center, Jackson, Mississippi
39216,1 and
Comprehensive Cancer
Center,2 and
Department of Laboratory
Medicine,3 Yale University School of
Medicine, New Haven, Connecticut 06520
Received 19 November 1997/Returned for modification 15 December
1997/Accepted 9 February 1998
 |
ABSTRACT |
Meglumine antimonate (Glucantime), a drug of choice for the
treatment of leishmaniasis, is produced by the reaction of pentavalent antimony with N-methyl-D-glucamine, a
carbohydrate derivative. We investigated the structure and composition
of meglumine antimonate, which remain poorly understood, despite 50 years of use. Measurement of the antimony content of meglumine
antimonate powder indicated a 1:1.37 molar ratio of antimony to
N-methyl-D-glucamine. Osmolality measurements
performed with meglumine antimonate solutions demonstrated an average
of 1.43 antimony atoms per molecule of meglumine antimonate. The
osmolality of a 1:10 dilution of stock meglumine antimonate increased
by 45% over 8 days, suggesting hydrolysis to less complex species. A
comparison of the proton nuclear magnetic resonance spectra of
N-methyl-D-glucamine and meglumine antimonate
revealed an increase in complexity in the latter but with all of the
resonances of the former still being evident, consistent with the
presence of coordination complexes between antimony and each of the
N-methyl-D-glucamine hydroxyls. Fast atom
bombardment and electrospray ionization mass spectrometry coupled with
several derivatization procedures provided evidence that up to four
N-methyl-D-glucamine hydroxyls are coordinated with each antimony. A series of oligomers were observed. The major moiety has a molecular mass of 507 atomic mass units and consists of
NMG-Sb-NMG, where Sb represents antimony and NMG represents N-methyl-D-glucamine. Additional species
containing up to four antimony atoms and five
N-methyl-D-glucamine moieties and corresponding to the general form (NMG-Sb)n-NMG are also
present. These results suggest that this agent is a complex mixture
that exists in equilibrium in aqueous solution.
 |
INTRODUCTION |
The protozoal parasite
Leishmania causes a spectrum of clinical diseases afflicting
12 million people worldwide (13). Two pentavalent antimonial
drugs, sodium stibogluconate (Pentostam) and meglumine antimonate
(Glucantime), are currently the agents of choice for the treatment of
leishmaniases and have been for 50 years. In spite of their wide use
for half a century, relatively little is known about either their
chemical structures or their mechanism(s) of action. Sodium
stibogluconate and meglumine antimonate are prepared by the reaction of
pentavalent antimony with gluconic acid and
N-methyl-D-glucamine, respectively. After the
initial reaction, the mixture is allowed to age, a step critical to
clinical effectiveness (see reference 9 and
references therein). Previous work on sodium stibogluconate suggested
that it was a complex mixture of components with apparent molecular
masses ranging from 100 to 4,000 Da (2). Efforts to obtain
detailed structural information about sodium stibogluconate by proton
(12) and carbon-13 (6) nuclear magnetic resonance
(NMR) spectroscopy were hampered by its complex nature. The clinical
effectiveness of sodium stibogluconate appears to be influenced by its
composition. Some lots of the drug have been associated with poor
clinical outcomes and have had higher osmolalities than clinically
effective lots (2). The higher osmolalities have been
presumed to reflect a diminished degree of sodium stibogluconate
polymerization. However, when sodium stibogluconate was fractionated by
anion-exchange chromatography into 10 fractions, all fractions showed
similar activities against Leishmania amastigotes in vitro
(8). These data suggest that subtle differences in the
composition of sodium stibogluconate (and possibly meglumine
antimonate) may be important for clinical antileishmanial activity. The
extent of polymerization may influence the pharmacokinetics of drug
delivery, uptake by the reticuloendothelial system, and the
intracellular distribution of pentavalent antimony.
Equally little is known about the structure and composition of
meglumine antimonate. Analogy with sodium stibogluconate suggests that
it may also be a complex mixture of carbohydrate-antimony polymers.
Data obtained by mass spectrometry have been used to propose a
structure in which two molecules of
N-methyl-D-glucamine are coordinated with a
single antimony atom (4). In this report osmolality
measurements, proton NMR, fast atom bombardment (FAB) mass spectrometry
(FAB-MS), and electrospray ionization (ES) mass spectrometry (ES-MS)
were used to obtain additional structural information on meglumine
antimonate. This information may aid in both the elucidation of the
mechanism of action of this agent and the rational design of new
antileishmanial drugs.
 |
MATERIALS AND METHODS |
Deuterium oxide (99.9 atom % deuterium),
N-methyl-D-glucamine, sodium cyanoborohydride
(95%), and sodium trimethylsilylpropionate were from Aldrich Chemical
Co. (Milwaukee, Wis.) and d4-methanol (99.9 atom
% deuterium) was from Sigma Chemical Co. (St. Louis, Mo.). Meglumine
antimonate (Rhone Poulenc, Paris, France) was provided by J. D. Berman at the Walter Reed Army Institute of Research (Washington,
D.C.).
The antimony contents of meglumine antimonate solutions were determined
by electrothermal atomic absorption spectroscopy with a Perkin-Elmer
4100 ZL spectrophotometer as described previously (7). The
osmolalities of meglumine antimonate solutions were measured by
freezing point depression on a One-Ten osmometer (Fiske Associates,
Needham, Mass.). The sodium and chloride ion contents of meglumine
antimonate solutions were determined with ion-selective electrodes on a
Hitachi model 717 automated chemistry analyzer (Boehringer Mannheim,
Indianapolis, Ind.). Deuterium exchange on meglumine antimonate or
thioglycerol was performed by repeated additions of deuterium oxide to
solutions dried on a Speed-Vac vacuum concentrator (Savant Instruments,
Farmingdale, N.Y.).
Reductive methylation prior to ES-MS was performed with an aqueous
solution of meglumine antimonate (35 mg/ml) by the addition of
formaldehyde and sodium cyanoborohydride (final concentrations of each,
0.5 M) followed by incubation at 25°C for 30 min. Insoluble material
was removed by centrifugation at 2,000 × g for 5 min. Methylated meglumine antimonate was precipitated from the reaction mixture by the addition of methanol (final concentration, 90%), and
the product was redissolved in water.
Acetylation of meglumine antimonate was carried out by mixing equal
volumes (100 µl each) of acetic anhydride and a stock solution of
meglumine antimonate (10 mg/ml). The reaction was allowed to proceed
for 24 to 48 h at room temperature. Peracetylation, the
acetylation of all free hydroxyl and amino groups, was performed in a
similar fashion, except equal volumes of pyridine, acetic anhydride,
and meglumine antimonate stock solution were added. The addition of
acetic anhydride and pyridine was repeated several times at 24-h
intervals. The course of each reaction was monitored by FAB-MS. Under
the reaction conditions used acetylation proceeded slowly.
Periodate oxidation was carried out by a modified procedure
(1) with a solution of meglumine antimonate (35 mg/ml) whose pH was adjusted to approximately 5 with acetic acid, using 8 mM sodium
periodate followed by incubation for at least 48 h. The extent of
the reaction was monitored by serial analysis by FAB-MS.
The proton NMR spectra of N-methyl-D-glucamine
and meglumine antimonate dissolved in 500 mM sodium phosphate-buffered
deuterium oxide (pH 7) were obtained on a Bruker AM 500-MHz
spectrometer. Chemical shifts are reported relative to those of sodium
trimethylsilylpropionate, which was added as an internal standard.
FAB mass spectra were recorded on a VG-ZAB-SE spectrometer (Micromass,
Manchester, United Kingdom) with a 35-kV cesium ion gun. ES spectra
were recorded on a VG-Quattro (Micromass) triple-quadrupole mass
spectrometer equipped with an Electrospray source (Analytica, Branford,
Conn.). FAB spectra were recorded by using thioglycerol as the matrix.
Deuterium exchange spectra were recorded by exchanging thioglycerol
with deuterium oxide several times. It was necessary to make several
insertions of the probe into the ion source with only deuterated
thioglycerol to remove residual protons and prevent the appearance of
meglumine antimonate species with incompletely exchanged protons.
ES spectra were recorded by using either the standard mode at flows of
1 µl/min or the pneumatically assisted mode at flows of 5 to 10 µl/min. In either case samples were introduced by direct infusion
with a syringe pump (Harvard Apparatus, Inc., South Natick, Mass.).
Spectra were recorded and processed with the standard VG software (OPUS
and MassLynx; Micromass).
Molecular modeling of meglumine antimonate was performed with the
Gaussian 94 suite of ab initio programs (Gaussian, Inc., Pittsburgh,
Pa.).
 |
RESULTS |
Aqueous solutions containing weighed amounts of meglumine
antimonate powder were prepared, and the antimony content of each solution was quantified by electrothermal atomic absorption
spectrophotometry. The average antimony content of the powder was
30.3% antimony on a weight basis. A liquid preparation of meglumine
antimonate (Glucantime) containing 80 mg of Sb/ml (657 mM) was found to
contain 58 mM sodium and 252 mM chloride. On the basis of these
analyses the amount of N-methyl-D-glucamine was
calculated by subtraction, and the mole ratio of antimony and
N-methyl-D-glucamine in meglumine antimonate was
estimated to be 1:1.37. Determinations of the osmolality of liquid
meglumine antimonate by freezing point depression were not
reproducible. Therefore, samples were diluted 1:10 with water and an
osmolality of 77 ± 1 mOsm/kg (n = 3) was measured
within 1 min after dilution. The extrapolated osmolarity of the
original solution was 770 mosM/L, with an average of 1.43 antimony
atoms per particle (because this dilution was volumetric, the
extrapolated result is in milliosmoles per liter [osmolarity]). When
liquid meglumine antimonate was diluted with water the osmolality of a
dilute solution increased by 45% over a period of 8 days.
Concomitantly, the pH decreased from 7.1 to 5.9 over the 8-day period.
A plot of osmolality versus time after a 1:10 dilution with water is shown in Fig. 1. On the basis of an
osmolality of 111 mosM/kg measured 8 days after dilution, diluted
meglumine antimonate was calculated to consist almost entirely of a 1:1
complex of antimony and N-methyl-D-glucamine,
some free N-methyl-D-glucamine, and sodium and
chloride ions. The predicted composition is based on the assumption of
negligible amounts of uncomplexed antimonic acid [hydrated antimony
(V) oxide], which is only very slightly soluble in water
(5).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Kinetics of increase in osmolality in diluted meglumine
antimonate. Stock meglumine antimonate (Glucantime) was diluted 1:10
with water at time zero, and osmolality was measured at intervals.
Measurements were made in duplicate at 6, 7, and 8 h and in
triplicate from 1 to 8 days. The points were fitted to a function with
two accumulation terms, yielding the equation y = 75.4 + 18.0(1 e 0.027t) + 16.9(1 e 1.01t)
(r2 = 0.987).
|
|
Proton NMR was used to characterize the carbohydrate species present in
meglumine antimonate in aqueous solution. A spectrum of
N-methyl-D-glucamine is shown in Fig.
2A, and spectra obtained from two
different preparations of meglumine antimonate are shown in Figs. 2B
and C, respectively. Both meglumine antimonate spectra contain all of
the proton resonances seen in
N-methyl-D-glucamine, as indicated by the
arrows. The relative intensity of these resonances is identical to that
observed in uncomplexed N-methyl-D-glucamine. New resonances were seen in meglumine antimonate at 1.3 ppm in one
preparation and at 1.2 and 1.3 ppm in another one. The methyl resonance
at 2.8 ppm is no longer a singlet but shows evidence of complex
coupling. Finally, the region from 3.0 to 4.6 ppm is markedly more
complex in the antimonial preparations than in the starting material,
with multiple additional resonances of varying complexity present both
up- and downfield from those in uncomplexed N-methyl-D-glucamine. A comparison of the
spectra obtained on the day of dissolution and 2 weeks later revealed
no apparent change in the spectra of either meglumine antimonate
preparation (data not shown). These results suggest that meglumine
antimonate is a complex mixture of
antimony-N-methyl-D-glucamine complexes with
protons residing in numerous chemical microenvironments.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 2.
Proton NMR spectra of
N-methyl-D-glucamine and meglumine antimonate.
Spectra of N-methyl-D-glucamine (A), dry
meglumine antimonate powder (B), and liquid meglumine antimonate dried
by vacuum centrifugation (C) were obtained for samples containing 100 mmol of each compound per liter dissolved in deuterium oxide containing
500 mM potassium phosphate (pH 7.0). No resonances were seen outside of
the region shown. The arrows in panels B and C indicate resonances in
common with panel A.
|
|
Positive-ion FAB-MS analysis of meglumine antimonate (Fig.
3A) revealed a number of ionized species.
On the basis of isotope ratios, most appear to have a charge of +1 such
that the mass/charge ratio (m/z) is equal to the molecular
weight. A major ion that does not contain antimony and that represents
protonated N-methyl-D-glucamine was observed at
m/z 196 (data not shown). All of the remaining ions in the
spectrum are easily characterized as containing antimony by the
distinctive isotope pattern of antimony (ratio of
121Sb:123Sb, 57:43). Ions containing one
antimony atom were observed at m/z 227, 314, 420, 507, and
525. Less abundant ion triplets containing two atoms of antimony were
observed and were centered on m/z 627 and 821. The
compositions and molecular weights of these species are summarized in
Table 1.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 3.
Positive-ion FAB mass spectra of meglumine antimonate
and peracetylated meglumine antimonate. The spectra of meglumine
antimonate (A) and peracetylated meglumine antimonate (B) were obtained
with a thioglycerol matrix. The sensitivity was increased 10-fold, as
indicated by the arrows.
|
|
In order to obtain additional information about meglumine antimonate
complexes, several derivatization procedures were performed. First,
reductive methylation of amino groups with formaldehyde and sodium
cyanoborohydride was performed. For each amino group proton replaced
there is an incremental mass increase of 14 atomic mass units (amu).
This permitted confirmation of the number of N-methyl-D-glucamine moieties present in each
species (Table 1) and also indicated that amino groups are not
complexed with antimony.
Meglumine antimonate was acetylated with acetic anhydride alone and
with a combination of acetic anhydride and pyridine to determine the
number of free hydroxyl and amino groups. The FAB spectrum of the
product from the reaction with acetic anhydride alone contained peaks
at m/z 549 and m/z 591 (data not shown), both
with the appropriate antimony isotope ratio, indicating the addition of
one and two acetyl groups, respectively, to the m/z 507 ion
in unacetylated material. Under these acetylation conditions, acetylation should occur only at an amino group. The FAB spectrum of
peracetylated meglumine antimonate (Fig. 3B) has ions at m/z 801 and 843 as a result of the addition of seven and eight acetyl groups, respectively, to m/z 507. These results are
compatible with a structure in which four hydroxyl groups from two
N-methyl-D-glucamine moieties are covalently
bonded to antimony (Fig. 4, structure 1).
Several higher-mass ions observed prior to acetylation and reductive
methylation were not observed after derivatization. This may have been
due to depolymerization during the derivatization process or to the
high background resulting from the high concentration of salt in the
reaction mixtures.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 4.
Proposed structures of the m/z 507 ion from
meglumine antimonate (structure 1) and the m/z 370 ion from
periodate oxidation of meglumine antimonate (structure 2). MW,
molecular weight.
|
|
Deuterium exchange of meglumine antimonate protons was performed with
deuterium oxide to determine the number of exchangeable protons present
in the major species observed by FAB-MS. The number of protons
exchanged was calculated from the mass increment observed for a given
peak after exchange (Table 1). The major ion at m/z 515 indicated the exchange of eight protons from the m/z 507 ion. This finding is again consistent with four
N-methyl-D-glucamine hydroxyl groups bonded with
antimony and the ability to incorporate a total of eight acetyl groups
(e.g., Fig. 4, structure 1). These deuterium exchange data are also
compatible with the m/z 507 ion being an M+ ion
and not an [M + H]+ ion because the latter would
require the incorporation of nine deuterium atoms.
ES-MS was used to obtain additional information about the overall
composition of meglumine antimonate. This is a softer ionization technique than FAB-MS and consequently may ionize larger molecular species without fragmentation. When the potential on the skimmer lens
in the electrospray ion source was initially set to 150 V, all of the
primary peaks were followed by a series of higher m/z peaks
at multiples of 18 amu (data not shown). When the skimmer potential was
increased to 300 V, the intensities of the higher-mass ions in each
group were reduced, presumably as a result of the removal of water
molecules, and the spectrum shown in Fig.
5A was produced. Some of the more
abundant higher-mass ions include ions of m/z 507, 820, 1131, and 1444. It was difficult to obtain reproducible intensities for
the higher-mass components. Satellite ions corresponding to the
addition of one or more water molecules were still visible even with
the higher skimmer potential.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 5.
Positive-ion ES mass spectra of meglumine antimonate.
The spectra of meglumine antimonate (A) and periodate oxidized
meglumine antimonate (B) were obtained.
|
|
Additional structural information on the major ions observed by ES-MS
was obtained by deuterium exchange and reductive methylation. After
deuterium exchange, satellite ions 20 amu larger were observed for ions
of m/z 515, 829, and 1141, indicating the formation of water
adducts. A summary of the results is presented in Table 2. Several ions observed prior to
reductive methylation were not observed after modification, probably
due to the high salt content of the reaction mixture. These results for
the major individual organoantimonial polymer components of meglumine
antimonate detected by ES-MS are compatible with the general formula of
(NMG-Sb)n-NMG, with n ranging from
one to four and where NMG is
N-methyl-D-glucamine. The molecular weight of
NMG-Sb of 314 may be predicted from those of
N-methyl-D-glucamine and antimony after the loss
of two protons during complex formation (195 + 121
2 = 314); the addition of another
N-methyl-D-glucamine moiety with the loss of two
more protons yields a total molecular weight of 507. The major ions observed at m/z 820, 1131, and 1444 correspond to the
addition of NMG-Sb units with the loss of protons during the
complexation process.
To determine whether specific
N-methyl-D-glucamine hydroxyl groups were
preferentially complexed with antimony, meglumine antimonate was
subjected to periodate oxidation. The ES-MS spectrum of the reaction
products (Fig. 5B) contains a new ion at m/z 370 (isotope
peaks not resolved), in addition to ions at m/z 196 and 507 that may be ascribed to residual unreacted material. Structure 2 (Fig.
4) is consistent with an ion of m/z 370 that is an oxidation product of an ion of m/z 507 that cannot be further oxidized
by periodate and that contains two
N-methyl-D-glucamine moieties complexed with
antimony in an asymmetric fashion. Specifically, the C-2 and C-3
hydroxyls of one N-methyl-D-glucamine and the C-4 and C-5 hydroxyls of the second
N-methyl-D-glucamine form bonds with an antimony
atom. Structure 1 (Fig. 4) is proposed for the m/z 507 ion
of meglumine antimonate observed by both FAB and ES.
 |
DISCUSSION |
Relatively little is known about the composition of pentavalent
antileishmanial drugs, despite their many years of use. Textbooks frequently suggest a dimeric structure for sodium stibogluconate in
which two antimony atoms are linked via an oxygen and each is
coordinated with one molecule of gluconate (11), although no
evidence for the structure is presented. (This may have been developed
in analogy to a structure for antimony potassium tartrate proposed
earlier [9], although the latter is now known to be a
cyclic dimer in which two tartrates are linked by coordination to two
bridging antimonies [10].) Berman and Grogl
(2) have shown, however, that sodium stibogluconate in fact
is a mixture of a number of components with apparent molecular weights
ranging from 100 to 4,000 and an overall composition of equimolar
amounts of antimony and sodium gluconate (2). On the basis
of mass spectral data, Headley et al. (4) proposed a
structure for meglumine antimonate in which two molecules of
N-methyl-D-glucamine are coordinately linked to
a single antimony. They observed by FAB-MS species containing up to
three antimony atoms, but they suggested that the larger aggregates
were formed under the ionization conditions and were not present at
significant levels in meglumine antimonate (4).
The studies that we report here suggest that meglumine antimonate
consists of a mixture of components with general formulas of
(NMG-Sb)n-NMG (major components; molecular
weights = 507, 820, 1132, and 1444) and
(NMG-Sb)n (minor components; molecular
weights = 314 and 627). Antimony and
N-methyl-D-glucamine alternate in these chains,
with each antimony coordinately linked via two hydroxyl groups from
each of the adjacent N-methyl-D-glucamine moieties. N-methyl-D-glucamine that are not in
terminal positions are linked to two antimonies (Fig.
6). The (NMG-Sb)2 component (molecular weight = 627) may have a cyclic structure. The linkages are relatively labile, and the relative amounts of the components are
in an equilibrium determined by the overall concentration, with a
higher concentration favoring an increased extent of oligomerization, possibly following simple mass action. The following evidence supports
these hypotheses.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 6.
Three-dimensional structure of an m/z 820 ion
from meglumine antimonate. The structure shown represents one meglumine
antimonate molecule containing two antimony atoms and three
N-methyl-D-glucamine moieties. The geometry of
structure 1 (Fig. 4) was optimized at the Hartree-Fock level by using
the LanL2DZ basis set. The optimized geometry was then used as a
subunit to construct the complete structure as shown. Hydrogen atoms
are light gray, carbon atoms are green, nitrogen atoms are blue, oxygen
atoms are red, and antimony atoms are yellow.
|
|
ES-MS data suggest that meglumine antimonate predominantly consists of
aggregates of antimony and
N-methyl-D-glucamine of the
general compositions
SbnNMGn and
SbnNMGn + 1, with the forms containing one more
N-methyl-D-glucamine moiety than antimony being
in greater abundance for any value of n (Fig. 5A; Table 2).
One must not presume that the mass spectrum accurately reflects the
composition of the starting material, since detection efficiency may
decrease with mass and some aggregation may occur as an artifact of the
electrospray process. The former effect would tend to underestimate the
abundance of higher-mass species, while the latter would tend to
produce an overestimate. Nonetheless, the overall composition from
ES-MS (determined by averaging the compositions of each species,
weighted by their relative abundances) agrees reasonably well with the
measured composition: The average N-methyl-D-glucamine-to-antimony molar ratio
derived from ES-MS was 1.45 and the average antimony-to-particle ratio
was 1.65. The measured values were an
N-methyl-D-glucamine:antimony mole ratio of 1.37 and a ratio of 1.43 antimony atoms per particle, derived from the
antimony content and osmolarity of liquid meglumine antimonate. The
concordance suggests that the ES-MS distribution provides at least a
qualitative picture of the composition of liquid meglumine antimonate
preparations.
Of note, while the general structure proposed by Headley et al.
(4) (SbNMG2; mass, 507) is the most abundant
form seen by ES-MS, it cannot be the sole species present in
N-methyl-D-glucamine, since it requires a 1:2
antimony:N-methyl-D-glucamine ratio and a 1:1
antimony-to-particle ratio.
The proton NMR spectrum of meglumine antimonate had all of the
resonances observed for free
N-methyl-D-glucamine and a number of unique
resonances as well. This pattern is consistent with the presence of
some free N-methyl-D-glucamine (<50% of the
total) or with a random association of
N-methyl-D-glucamine hydroxyl groups with
antimony such that each chemically distinct hydroxyl group is found
both uncomplexed and complexed with antimony. The former hypothesis is
supported by the observation of free
N-methyl-D-glucamine in the mass spectra at
m/z 196, although this ion could also arise by fragmentation
of larger species. Daughter ion analysis of the m/z 507 ion
after collision-induced dissociation did not reveal a major ion at
m/z 196 (data not shown), which argues against the
m/z 196 ion arising principally from fragmentation. The
additional variety of proton resonances observed for meglumine
antimonate in the region from 4.6 to 2.8 ppm are compatible with
multiple unique microenvironments, both shielded and deshielded, for
N-methyl-D-glucamine protons. The NMR spectrum
is consistent with meglumine antimonate comprising a variety of related
structures rather than a single structure.
The spectra obtained by FAB-MS and ES-MS are similar, but some
higher-mass species seen in the latter are not seen in the former. This
may be a consequence of the inability of FAB to ionize larger
components without fragmenting them. A component of m/z 420 was found by FAB-MS but not by ES-MS. This m/z corresponds to an antimony coordinated with one molecule of
N-methyl-D-glucamine and one molecule of
thioglycerol, the FAB matrix. Headley et al. (4) attributed
an m/z 404 ion found by FAB-MS with glycerol as the matrix
to fragmentation, but it could also have been the corresponding adduct
with glycerol. Since we found no ions at m/z 404 and the
previous report noted none at m/z 420, adduct formation with
the matrix is the most likely explanation.
The ready formation of adducts with the matrix, probably by exchange
for an N-methyl-D-glucamine, suggests that the
coordinate links between the antimony and the hydroxyls of the
N-methyl-D-glucamine are relatively labile. This
was further shown by experiments in which concentrated preparations
were diluted 10-fold with water. This resulted in a subsequent increase
in osmolality of the solution over time, as well as a decrease in pH
(Fig. 1). The probable explanation for this behavior is the hydrolysis
of the more polymerized species into simpler ones, with an accompanying
increase in the number of particles. Given the relative lability of the
coordination linkages, one would expect increasing depolymerization
with increasing dilution on the basis of simple mass action effects
(the overall reaction is simply replacement of a coordinated organic
hydroxyl with a water-derived hydroxyl). Replacement of organic
hydroxyl groups with water in the coordination complex with antimony
would be expected to result in the generation of acidic protons and to
lower the pH. A decrease in pH with time has been observed for
arylstibonic acids treated with alkali (3). These
observations are fully consistent with the concept that simple
N-methyl-D-glucamine complexes with antimony are
in reversible equilibrium with more complex forms.
The increase in osmolality showed complex kinetics, which might be
expected with the wide variety of species capable of undergoing hydrolysis. The time course of the hydrolysis could be reasonably modeled by the equation y = 75.4 + 18.0(1
e
0.027t) + 16.9(1
e
1.01t). This suggests that
hydrolysis events could be grouped into two sets, one with a half-life
of about 40 min and the other with a half-life of about 26 h.
The methylation and acetylation experiments, as well as deuterium
exchange, were carried out to characterize more specifically the way in
which the antimony and N-methyl-D-glucamine are
linked in the complexes. Previously, when FAB-MS and ES-MS were used to
partially characterize meglumine antimonate, the investigators (4) proposed a symmetric structure in which antimony was
bonded to the hydroxyls at the C-4 and C-6 positions of two
N-methyl-D-glucamine to form six-membered rings.
We hypothesize that the chemical reaction to form meglumine antimonate
is consistent with the following general reaction scheme:
One would expect that the basic nitrogen of the
N-methyl-
D-glucamine would be easily protonated
to produce a molecular ion.
However, the formation of a protonated
amine on meglumine antimonate
would be hindered at neutral pH by
electrostatic repulsion from
the positively charged antimony. This
would explain our observation
of an M
+ ion (based on
deuterium exchange and peracetylation experiments)
rather than an
[M + H]
+ ion. The formation of the [M + H]
+ ion had previously been observed when hydrochloric
acid was added
to the glycerol matrix (
4).
Our FAB-MS and ES-MS results for meglumine antimonate and its
derivatives are most compatible with four oxygen atoms from two
N-methyl-D-glucamine molecules being bonded to a
pentavalent antimony atom in the most abundant species (m/z
507). Our data do not allow specification of the specific hydroxyls
involved in the coordination complexes. However, the data for the
m/z 507 species (Fig. 4) do suggest that when specific
hydroxyls coordinate with antimony, the resulting complex is more
resistant to periodate oxidation. The complexities of the NMR patterns
suggest that multiple possible sets of linkages may be present.
We have drawn our proposed structures as involving coordination with
vicinal hydroxyls (e.g., structure 1 in Fig. 4). This follows the
pattern observed for antimony potassium tartrate and is most consistent
with the structure of the major ion at m/z 370 observed
after periodate oxidation (structure 2, Fig. 4). On the basis of
structure 2, structure 1 is proposed as being most likely for the
dominant m/z 507 ion observed by both FAB-MS and ES-MS.
Figure 6 provides one possible three-dimensional structure for
(NMG-Sb)2-NMG that is representative of oligomeric
structures that are expected to be present in meglumine antimonate,
based on the data that we have presented.
 |
ACKNOWLEDGMENTS |
This work was supported in part by Merck/American Federation for
Clinical Research Foundation (postdoctoral fellowship to W.L.R.), by
the University of Mississippi Medical Center (Biomedical Research Grant
award to W.L.R.), and by the AB Foundation for Medical Research
(protocol 92-02 to P.M.R.). NMR instrumentation facilities were
provided by NIH (grant RR03475), NSF (grant DMB8610557), and ACS (grant
RD259) grants. Mass spectrometer instrumentation facilities were
provided by an NIH Shared Instrumentation grant (grant RR05358).
We thank Guiseppe Giordano and Yufang Zheng for technical assistance
and Ian Armitage and Jack Faller for helpful discussions and critical
review of the manuscript. We gratefully acknowledge Steven Davis for
preparing the three-dimensional molecular model for Fig. 6.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology, University of Mississippi Medical Center, 2500 North State St., Jackson, MS 39216. Phone: (601) 984-2374. Fax: (601) 984-2885. E-mail: wroberts{at}pathology.umsmed.edu.
 |
REFERENCES |
| 1.
|
Angel, A.-S., and B. Nilsson.
1990.
Linkage positions in glycoconjugates by periodate oxidation and fast atom bombardment mass spectrometry.
Methods Enzymol.
193:587-607[Medline].
|
| 2.
|
Berman, J. D., and M. Grogl.
1988.
Leishmania mexicana: chemistry and biochemistry of sodium stibogluconate (Pentostam).
Exp. Parasitol.
67:96-103[Medline].
|
| 3.
|
Doak, G. O., and L. D. Freedman.
1960.
Organometallic compounds of arsenic, antimony and bismuth, p. 291.
Wiley-Interscience, New York, N.Y.
|
| 4.
|
Headley, J. V.,
M. S. Yong,
P. W. Brooks, and A. Phillips.
1995.
Fast-atom bombardment mass spectrometry of the organometallic parasiticide, meglumine antimonate.
Rapid Commun. Mass Spectrom.
9:372-376.
|
| 5.
|
Lide, D. R. (ed.).
1996.
CRC handbook of chemistry and physics, 77th ed., p. 4-41.
CRC Press, New York, N.Y.
|
| 6.
|
Masamori, E.,
A. Benitez, and P. Lim.
1986.
Assay of sodium stibogluconate (Pentostam). Report no. 552; contract no. DAMD17-85-C-5141.
United States Army Medical Research and Development Command, Office of the Surgeon General, Washington, D.C.
|
| 7.
|
Roberts, W. L., and P. M. Rainey.
1993.
Antimony quantification in Leishmania by electrothermal atomic absorption spectroscopy.
Anal. Biochem.
211:1-6[Medline].
|
| 8.
|
Roberts, W. L., and P. M. Rainey.
1993.
Antileishmanial activity of sodium stibogluconate fractions.
Antimicrob. Agents Chemother.
37:1842-1846[Abstract/Free Full Text].
|
| 9.
|
Steck, E. A.
1974.
The leishmaniases.
Prog. Drug Res.
18:289-351[Medline].
|
| 10.
|
Tapscott, R. E.,
R. L. Belford, and I. C. Paul.
1969.
Stereochemistry of tartrato(4-)-bridged binuclear complexes.
Coord. Chem. Rev.
4:323-359.
|
| 11.
|
Tracy, J. W., and L. T. Webster.
1996.
Chemotherapy of parasitic infections, p. 987-1008.
In
J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman (ed.), Goodman & Gilman's the pharmacological basis of therapeutics, 9th ed. McGraw-Hill Book Co., New York, N.Y.
|
| 12.
| Watnick, P. I., and P. M. Rainey.
Unpublished data.
|
| 13.
|
World Health Organization.
1990.
Control of the leishmaniases, p. 9-15.
In
Report of a WHO expert committee. World Health Organization Technical Report Services Report no. 793. World Health Organization, Geneva, Switzerland.
|
Antimicrobial Agents and Chemotherapy, May 1998, p. 1076-1082, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Amato, V. S., Tuon, F. F., Siqueira, A. M., Nicodemo, A. C., Neto, V. A.
(2007). Treatment of Mucosal Leishmaniasis in Latin America: Systematic Review. Am J Trop Med Hyg
77: 266-274
[Abstract]
[Full Text]
-
Shaked-Mishan, P., Ulrich, N., Ephros, M., Zilberstein, D.
(2001). Novel Intracellular SbV Reducing Activity Correlates with Antimony Susceptibility in Leishmania donovani. J. Biol. Chem.
276: 3971-3976
[Abstract]
[Full Text]